PetMed Express Inc (PETS) (Q2 2027) Earnings Call Highlights: New CEO Charts Multiyear ...
PetMed: Fiscal Q2 Earnings Snapshot
PetMeds® Announces Second Quarter Financial Results
PetMed Express Q2 2027 Earnings Call Transcript
PetMed Express, Inc. (PETS) Q2 2027 Earnings Call Prepared Remarks Transcript
PetMed Express Q2 EPS $(0.31) Misses $(0.11) Estimate, Sales $35.770M Beat $7.222M Estimate
PetMeds Announces Strategic Partnership with Pet Supermarket to Expand Pharmacy Offering Across Retail and Digital Channels
PetMeds Partners With Pet Supermarket To Offer Pet Prescription Medications, Preventatives And Health Products To Pet Parents Across Pet Supermarket’s Retail Stores And Digital Platforms
PetMed Express, Inc. to Report Second Quarter Fiscal Year 2027 Financial Results on Tuesday, November 10, 2026
PetMeds Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Morgan Stanley Maintains Underweight on PetMed Express, Lowers Price Target to $1.4
PetMeds Enhances Board of Directors with Appointment of Tamar Elkeles as New Independent Director
PetMeds Appoints Jeff Willard as CEO & President and Announces Board Leadership Transition
PetMeds Appoints Andrew Parry as Chief Technology Officer
PetMed Express (PETS) Q1 2027 Earnings Call Transcript
PetMed Express Q1 Earnings Miss Estimates, Sales Decline Y/Y
PetMed Express Inc (PETS) (Q1 2027) Earnings Call Highlights: Narrowing Losses and Strategic ...
PetMeds® Announces First Quarter Financial Results
PetMed Express, Inc. (PETS) Q1 2027 Earnings Call Prepared Remarks Transcript
Full Transcript: PetMed Express Q1 2027 Earnings Call
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.